TGFBR1 and myeloproliferative neoplasm: Looking more specifically into the TGFb1 ligand–receptor pairs, we observed an upregulation of the TGFb1–TGFbR1 interactions between monocyte subtypes and MSCs in JAK2V617F‐mediated MPN compared to control.